Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance.

Lu, Yonggang; Shen, Haoming; Huang, Wenjie; He, Sha; Chen, Jianlin; Zhang, Di; Shen, Yongqi; Sun, Yifan

Lu, Yonggang; Shen, Haoming; Huang, Wenjie; He, Sha; Chen, Jianlin; Zhang, Di; Shen, Yongqi; Sun, Yifan.

Afiliação

Lu Y; Department of Hepatobiliary Surgery, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
Shen H; Department of Clinical Laboratory, Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan, China.
Huang W; Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
He S; Department of Hepatobiliary Surgery, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
Chen J; Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China.
Zhang D; Department of Clinical Laboratory, The Third Xiangya Hospital of Central South University, Hunan, China.
Shen Y; Department of Oncology, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China. gxnnsyq@163.com.
Sun Y; Department of Clinical Laboratory, Affiliated Liutie Central Hospital of Guangxi Medical University, Guangxi, China. sunyifan@gxmu.edu.cn.

Cell Death Discov ; 7(1): 359, 2021 Nov 18.

Article em En | MEDLINE | ID: mdl-34795217

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Cell Death Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google